BioStem Technologies (BioStem Technologies) Total Liabilities : $9.34 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies Total Liabilities?

BioStem Technologies's Total Liabilities for the quarter that ended in Sep. 2023 was $9.34 Mil.

BioStem Technologies's quarterly Total Liabilities increased from Dec. 2022 ($7.42 Mil) to Mar. 2023 ($7.67 Mil) and increased from Mar. 2023 ($7.67 Mil) to Sep. 2023 ($9.34 Mil).

BioStem Technologies's annual Total Liabilities increased from Dec. 2020 ($8.30 Mil) to Dec. 2021 ($8.47 Mil) but then declined from Dec. 2021 ($8.47 Mil) to Dec. 2022 ($7.42 Mil).

BioStem Technologies Total Liabilities Historical Data

The historical data trend for BioStem Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies Total Liabilities Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

5.97

7.09

8.30

8.47

7.42

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
Total Liabilities	Get a 7-Day Free Trial															-	-	7.42	7.67	9.34

BioStem Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BioStem Technologies's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.328	+	(1.038	+	0.05
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.42

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	3.466	-	-3.95
	=	7.42

BioStem Technologies's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.907	+	(1.41	+	0.023
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	9.34

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	5.814	-	-3.526
	=	9.34

BioStem Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.